AMPK activation: a therapeutic target for type 2 diabetes?

References

• International Diabetes Federation Diabetes Atlas 6th ed Brussels, Belgium International Diabetes Federation 2013
   Google Scholar
• Ruderman N Prentki M AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome Nat Rev Drug Discov 2004 3 4 340 351 15060529
   PubMed Web of Science ®Google Scholar
• Ruderman NB Carling D Prentki M Cacicedo JM AMPK, insulin resistance, and the metabolic syndrome J Clin Invest 2013 123 7 2764 2772 23863634
   PubMed Web of Science ®Google Scholar
• Coughlan KA Valentine RJ Ruderman NB Saha AK Nutrient excess in AMPK downregulation and insulin resistance Journal of Endocrinology, Diabetes and Obesity 2013 1 1 1008
   Google Scholar
• O’Neill HM AMPK and exercise: glucose uptake and insulin sensitivity Diabetes Metab J 2013 37 1 1 21 23441028
   PubMedGoogle Scholar
• Steinberg GR Kemp BE AMPK in Health and Disease Physiol Rev 2009 89 3 1025 1078 19584320
   PubMed Web of Science ®Google Scholar
• Birnbaum MJ Activating AMP-activated protein kinase without AMP Mol Cell 2005 19 3 289 290 16061173
   PubMed Web of Science ®Google Scholar
• Lizcano JM Göransson O Toth R LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1 EMBO J 2004 23 4 833 843 14976552
   PubMed Web of Science ®Google Scholar
• Woods A Johnstone SR Dickerson K LKB1 is the upstream kinase in the AMP-activated protein kinase cascade Curr Biol 2003 13 22 2004 2008 14614828
   PubMed Web of Science ®Google Scholar
• Hawley SA Pan DA Mustard KJ Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase Cell Metab 2005 2 1 9 19 16054095
   PubMed Web of Science ®Google Scholar
• Momcilovic M Hong SP Carlson M Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro J Biol Chem 2006 281 35 25336 25343 16835226
   PubMed Web of Science ®Google Scholar
• Horman S Vertommen D Heath R Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491 J Biol Chem 2006 281 9 5335 5340 16340011
   PubMed Web of Science ®Google Scholar
• Ning J Xi G Clemmons DR Suppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cells Endocrinology 2011 152 8 3143 3154 21673100
   PubMed Web of Science ®Google Scholar
• Hurley RL Barré LK Wood SD Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP J Biol Chem 2006 281 48 36662 36672 17023420
   PubMed Web of Science ®Google Scholar
• Pulinilkunnil T He H Kong D Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo J Biol Chem 2011 286 11 8798 8809 21209093
   PubMed Web of Science ®Google Scholar
• Berggreen C Gormand A Omar B Degerman E Göransson O Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes Am J Physiol Endocrinol Metab 2009 296 4 E635 E646 19158325
   PubMed Web of Science ®Google Scholar
• Dagon Y Hur E Zheng B Wellenstein K Cantley LC Kahn BB p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin’s effect on food intake Cell Metab 2012 16 1 104 112 22727014
   PubMed Web of Science ®Google Scholar
• Hawley SA Ross FA Gowans GJ Tibarewal P Leslie NR Hardie DG Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells Biochem J 2014 459 2 275 287 24467442
   PubMed Web of Science ®Google Scholar
• Xiao B Heath R Saiu P Structural basis for AMP binding to mammalian AMP-activated protein kinase Nature 2007 449 7161 496 500 17851531
   PubMed Web of Science ®Google Scholar
• Chen L Wang J Zhang YY AMP-activated protein kinase undergoes nucleotide-dependent conformational changes Nat Struct Mol Biol 2012 19 7 716 718 22659875
   PubMed Web of Science ®Google Scholar
• Hawley SA Selbert MA Goldstein EG Edelman AM Carling D Hardie DG 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms J Biol Chem 1995 270 45 27186 27191 7592975
   PubMed Web of Science ®Google Scholar
• Davies SP Helps NR Cohen PT Hardie DG 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC FEBS Lett 1995 377 3 421 425 8549768
   PubMed Web of Science ®Google Scholar
• Suter M Riek U Tuerk R Schlattner U Wallimann T Neumann D Dissecting the role of 5′-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase J Biol Chem 2006 281 43 32207 32216 16943194
   PubMed Web of Science ®Google Scholar
• Gowans GJ Hawley SA Ross FA Hardie DG AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation Cell Metab 2013 18 4 556 566 24093679
   PubMed Web of Science ®Google Scholar
• Xiao B Sanders MJ Underwood E Structure of mammalian AMPK and its regulation by ADP Nature 2011 472 7342 230 233 21399626
   PubMed Web of Science ®Google Scholar
• Oakhill JS Steel R Chen ZP AMPK is a direct adenylate charge-regulated protein kinase Science 2011 332 6036 1433 1435 21680840
   PubMed Web of Science ®Google Scholar
• Munday MR Campbell DG Carling D Hardie DG Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase Eur J Biochem 1988 175 2 331 338 2900138
   PubMedGoogle Scholar
• Inoki K Zhu T Guan KL TSC2 mediates cellular energy response to control cell growth and survival Cell 2003 115 5 577 590 14651849
   PubMed Web of Science ®Google Scholar
• Clarke PR Hardie DG Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver EMBO J 1990 9 8 2439 2446 2369897
   PubMed Web of Science ®Google Scholar
• Jäger S Handschin C St-Pierre J Spiegelman BM AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha Proc Natl Acad Sci U S A 2007 104 29 12017 12022 17609368
   PubMed Web of Science ®Google Scholar
• Zong H Ren JM Young LH AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation Proc Natl Acad Sci U S A 2002 99 25 15983 15987 12444247
   PubMed Web of Science ®Google Scholar
• Srivastava RA Pinkosky SL Filippov S Hanselman JC Cramer CT Newton RS AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases J Lipid Res 2012 53 12 2490 2514 22798688
   PubMed Web of Science ®Google Scholar
• Minokoshi Y Alquier T Furukawa N AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus Nature 2004 428 6982 569 574 15058305
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay GK Yu JG Ofrecio J Olefsky JM Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects Diabetes 2006 55 8 2277 2285 16873691
   PubMed Web of Science ®Google Scholar
• Xu XJ Gauthier MS Hess DT Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue J Lipid Res 2012 53 4 792 801 22323564
   PubMed Web of Science ®Google Scholar
• Fogarty S Hardie DG Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer Biochim Biophys Acta 2010 1804 3 581 591 19778642
   PubMed Web of Science ®Google Scholar
• Richter EA Ruderman NB AMPK and the biochemistry of exercise: implications for human health and disease Biochem J 2009 418 2 261 275 19196246
   PubMed Web of Science ®Google Scholar
• Winder WW Hardie DG Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise Am J Physiol 1996 270 2 Pt 1 E299 E304 8779952
   PubMed Web of Science ®Google Scholar
• Hayashi T Hirshman MF Kurth EJ Winder WW Goodyear LJ Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport Diabetes 1998 47 8 1369 1373 9703344
   PubMed Web of Science ®Google Scholar
• Hutber CA Hardie DG Winder WW Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase Am J Physiol 1997 272 2 Pt 1 E262 E266 9124333
   PubMed Web of Science ®Google Scholar
• Vavvas D Apazidis A Saha AK Contraction-induced changes in acetyl-CoA carboxylase and 5’-AMP-activated kinase in skeletal muscle J Biol Chem 1997 272 20 13255 13261 9148944
   PubMed Web of Science ®Google Scholar
• Park H Kaushik VK Constant S Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise J Biol Chem 2002 277 36 32571 32577 12065578
   PubMed Web of Science ®Google Scholar
• Wojtaszewski JF Nielsen P Hansen BF Richter EA Kiens B Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle J Physiol 2000 528 Pt 1 221 226 11018120
   PubMed Web of Science ®Google Scholar
• Chen ZP Stephens TJ Murthy S Effect of exercise intensity on skeletal muscle AMPK signaling in humans Diabetes 2003 52 9 2205 2212 12941758
   PubMed Web of Science ®Google Scholar
• Fujii N Hayashi T Hirshman MF Exercise induces isoform-specific increase in 5′AMP-activated protein kinase activity in human skeletal muscle Biochem Biophys Res Commun 2000 273 3 1150 1155 10891387
   PubMed Web of Science ®Google Scholar
• Sahlin K Tonkonogi M Söderlund K Energy supply and muscle fatigue in humans Acta Physiol Scand 1998 162 3 261 266 9578371
   PubMedGoogle Scholar
• O’Neill HM Maarbjerg SJ Crane JD AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise Proc Natl Acad Sci U S A 2011 108 38 16092 16097 21896769
   PubMed Web of Science ®Google Scholar
• Lantier L Fentz J Mounier R AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity FASEB J Epub 3 20 2014
   Web of Science ®Google Scholar
• Corton JM Gillespie JG Hawley SA Hardie DG 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 1995 229 2 558 565 7744080
   PubMedGoogle Scholar
• Sullivan JE Brocklehurst KJ Marley AE Carey F Carling D Beri RK Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase FEBS Lett 1994 353 1 33 36 7926017
   PubMed Web of Science ®Google Scholar
• Song XM Fiedler M Galuska D 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice Diabetologia 2002 45 1 56 65 11845224
   PubMed Web of Science ®Google Scholar
• Bergeron R Previs SF Cline GW Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats Diabetes 2001 50 5 1076 1082 11334411
   PubMed Web of Science ®Google Scholar
• Buhl ES Jessen N Schmitz O Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner Diabetes 2001 50 1 12 17 11147776
   PubMed Web of Science ®Google Scholar
• Iglesias MA Ye JM Frangioudakis G AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats Diabetes 2002 51 10 2886 2894 12351423
   PubMed Web of Science ®Google Scholar
• Narkar VA Downes M Yu RT AMPK and PPARdelta agonists are exercise mimetics Cell 2008 134 3 405 415 18674809
   PubMed Web of Science ®Google Scholar
• Thomas A Beuck S Eickhoff JC Quantification of urinary AICAR concentrations as a matter of doping controls Anal Bioanal Chem 2010 396 8 2899 2908 20225061
   PubMed Web of Science ®Google Scholar
• Vincent MF Marangos PJ Gruber HE Van den Berghe G Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes Diabetes 1991 40 10 1259 1266 1657665
   PubMed Web of Science ®Google Scholar
• Longnus SL Wambolt RB Parsons HL Brownsey RW Allard MF 5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms Am J Physiol Regul Integr Comp Physiol 2003 284 4 R936 R944 12626360
   PubMed Web of Science ®Google Scholar
• Sengupta TK Leclerc GM Hsieh-Kinser TT Leclerc GJ Singh I Barredo JC Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy Mol Cancer 2007 6 46 17623090
   PubMed Web of Science ®Google Scholar
• Leclerc GM Leclerc GJ Fu G Barredo JC AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia J Mol Signal 2010 5 15 20863384
   PubMedGoogle Scholar
• Mullane K Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury Cardiovasc Res 1993 27 1 43 47 8458030
   PubMed Web of Science ®Google Scholar
• Mangano DT Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group JAMA 1997 277 4 325 332 9002496
   PubMed Web of Science ®Google Scholar
• Gomez-Galeno JE Dang Q Nguyen TH A potent and selective AMPK activator that inhibits de novo lipogenesis ACS Med Chem Lett 2010 1 478 482 24900234
   PubMed Web of Science ®Google Scholar
• Rena G Pearson ER Sakamoto K Molecular mechanism of action of metformin: old or new insights? Diabetologia 2013 56 9 1898 1906 23835523
   PubMed Web of Science ®Google Scholar
• Nathan DM Buse JB Davidson MB American Diabetes Association European Association for the Study of Diabetes Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia 2009 52 1 17 30 18941734
   PubMed Web of Science ®Google Scholar
• Inzucchi SE Bergenstal RM Buse JB Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 2012 55 6 1577 1596 22526604
   PubMed Web of Science ®Google Scholar
• Rodbard HW Jellinger PS Davidson JA Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control Endocr Pract 2009 15 6 540 559 19858063
   PubMed Web of Science ®Google Scholar
• Witters LA The blooming of the French lilac J Clin Invest 2001 108 8 1105 1107 11602616
   PubMed Web of Science ®Google Scholar
• Bailey CJ Day C Metformin: its botanical background Practical Diabetes International 2004 21 3 115 117
   Google Scholar
• Mehnert H Metformin, the rebirth of a biguanide: mechanism of action and place in the prevention and treatment of insulin resistance Exp Clin Endocrinol Diabetes 2001 109 Suppl 2 S259 S264 11460576
   PubMed Web of Science ®Google Scholar
• Srinivasan B Taub N Khunti K Davies M Diabetes: glycaemic control in type 2 Clin Evid (Online) 2008 2008 pii: 0609
   Google Scholar
• Haffner S Temprosa M Crandall J Diabetes Prevention Program Research Group Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance Diabetes 2005 54 5 1566 1572 15855347
   PubMed Web of Science ®Google Scholar
• Buzzai M Jones RG Amaravadi RK Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth Cancer Res 2007 67 14 6745 6752 17638885
   PubMed Web of Science ®Google Scholar
• Evans JM Donnelly LA Emslie-Smith AM Alessi DR Morris AD Metformin and reduced risk of cancer in diabetic patients BMJ 2005 330 7503 1304 1305 15849206
   PubMed Web of Science ®Google Scholar
• Zhou G Myers R Li Y Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 2001 108 8 1167 1174 11602624
   PubMed Web of Science ®Google Scholar
• Shaw RJ Lamia KA Vasquez D The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin Science 2005 310 5754 1642 1646 16308421
   PubMed Web of Science ®Google Scholar
• Owen MR Doran E Halestrap AP Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem J 2000 348 Pt 3 607 614 10839993
   PubMed Web of Science ®Google Scholar
• Hawley SA Gadalla AE Olsen GS Hardie DG The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism Diabetes 2002 51 8 2420 2425 12145153
   PubMed Web of Science ®Google Scholar
• Hawley SA Ross FA Chevtzoff C Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation Cell Metab 2010 11 6 554 565 20519126
   PubMed Web of Science ®Google Scholar
• Turban S Stretton C Drouin O Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells J Biol Chem 2012 287 24 20088 20099 22511782
   PubMed Web of Science ®Google Scholar
• Foretz M Hébrard S Leclerc J Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state J Clin Invest 2010 120 7 2355 2369 20577053
   PubMed Web of Science ®Google Scholar
• Miller RA Chu Q Xie J Foretz M Viollet B Birnbaum MJ Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP Nature 2013 494 7436 256 260 23292513
   PubMed Web of Science ®Google Scholar
• Fullerton MD Galic S Marcinko K Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin Nat Med 2013 19 12 1649 1654 24185692
   PubMed Web of Science ®Google Scholar
• Fryer LG Parbu-Patel A Carling D The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J Biol Chem 2002 277 28 25226 25232 11994296
   PubMed Web of Science ®Google Scholar
• LeBrasseur NK Kelly M Tsao TS Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues Am J Physiol Endocrinol Metab 2006 291 1 E175 E181 16464908
   PubMed Web of Science ®Google Scholar
• Saha AK Avilucea PR Ye JM Assifi MM Kraegen EW Ruderman NB Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo Biochem Biophys Res Commun 2004 314 2 580 585 14733947
   PubMed Web of Science ®Google Scholar
• Brunmair B Staniek K Gras F Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 2004 53 4 1052 1059 15047621
   PubMed Web of Science ®Google Scholar
• Suzuki H Eguchi S Adiponectin versus angiotensin II: Key pathological role of their misbalance Kidney Int 2006 70 10 1678 1679 17080158
   PubMed Web of Science ®Google Scholar
• Kubota N Terauchi Y Kubota T Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways J Biol Chem 2006 281 13 8748 8755 16431926
   PubMed Web of Science ®Google Scholar
• Yau H Rivera K Lomonaco R Cusi K The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus Curr Diab Rep 2013 13 3 329 341 23625197
   PubMed Web of Science ®Google Scholar
• He S Tang YH Zhao G Yang X Wang D Zhang Y Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis Tumour Biol 2014 35 3 2095 2102 24092576
   PubMedGoogle Scholar
• Home PD Pocock SJ Beck-Nielsen H RECORD Study Group Rosiglitazone evaluated for cardiovascular outcomes – an interim analysis N Engl J Med 2007 357 1 28 38 17551159
   PubMed Web of Science ®Google Scholar
• Hwang JI Yun S Moon MJ Park CR Seong JY Evolution of GLP1 and GLP1 receptor J Mol Endocrinol Epub 3 5 2014
   Web of Science ®Google Scholar
• Baggio LL Drucker DJ Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review Treat Endocrinol 2002 1 117 125 15765627
   PubMedGoogle Scholar
• Deacon CF Holst JJ Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety Expert Opin Pharmacother 2013 14 15 2047 2058 23919507
   PubMed Web of Science ®Google Scholar
• Svegliati-Baroni G Saccomanno S Rychlicki C Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis Liver Int 2011 31 9 1285 1297 21745271
   PubMed Web of Science ®Google Scholar
• Lee J Hong SW Chae SW Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice PLoS One 2012 7 2 e31394 22363635
   PubMed Web of Science ®Google Scholar
• Cool B Zinker B Chiou W Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome Cell Metab 2006 3 6 403 416 16753576
   PubMed Web of Science ®Google Scholar
• Göransson O McBride A Hawley SA Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase J Biol Chem 2007 282 45 32549 32560 17855357
   PubMed Web of Science ®Google Scholar
• Sanders MJ Ali ZS Hegarty BD Heath R Snowden MA Carling D Defining the mechanism of activation of AMP-activated protein kinase by the small molecule A-769662, a member of the thienopyridone family J Biol Chem 2007 282 45 32539 32548 17728241
   PubMed Web of Science ®Google Scholar
• Xiao B Sanders MJ Carmena D Structural basis of AMPK regulation by small molecule activators Nat Commun 2013 4 3017 24352254
   PubMed Web of Science ®Google Scholar
• Scott JW van Denderen BJ Jorgensen SB Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes Chem Biol 2008 15 11 1220 1230 19022182
   PubMedGoogle Scholar
• Moreno D Knecht E Viollet B Sanz P A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism FEBS Lett 2008 582 17 2650 2654 18593584
   PubMed Web of Science ®Google Scholar
• Reymond P Farmer EE Jasmonate and salicylate as global signals for defense gene expression Curr Opin Plant Biol 1998 1 5 404 411 10066616
   PubMed Web of Science ®Google Scholar
• Jeffreys D Aspirin: The Remarkable Story of a Wonder Drug London, UK Bloomsbury Publishing 2004
   Google Scholar
• Miners JO Grgurinovich N Whitehead AG Robson RA Birkett DJ Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid Br J Clin Pharmacol 1986 22 2 135 142 3756063
   PubMed Web of Science ®Google Scholar
• Higgs GA Salmon JA Henderson B Vane JR Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity Proc Natl Acad Sci U S A 1987 84 5 1417 1420 3103135
   PubMed Web of Science ®Google Scholar
• Hawley SA Fullerton MD Ross FA The ancient drug salicylate directly activates AMP-activated protein kinase Science 2012 336 6083 918 922 22517326
   PubMed Web of Science ®Google Scholar
• Fleischman A Shoelson SE Bernier R Goldfine AB Salsalate improves glycemia and inflammatory parameters in obese young adults Diabetes Care 2008 31 2 289 294 17959861
   PubMed Web of Science ®Google Scholar
• Goldfine AB Conlin PR Halperin F A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance Diabetologia 2013 56 4 714 723 23370525
   PubMed Web of Science ®Google Scholar
• Pang T Zhang ZS Gu M Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells J Biol Chem 2008 283 23 16051 16060 18321858
   PubMed Web of Science ®Google Scholar
• Li YY Yu LF Zhang LN Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice Toxicol Appl Pharmacol 2013 273 2 325 334 24055643
   PubMed Web of Science ®Google Scholar
• Yu LF Li YY Su MB Development of novel alkene oxindole derivatives as orally efficacious AMP-activated protein kinase activators ACS Med Chem Lett 2013 4 5 475 480 24900695
   PubMed Web of Science ®Google Scholar
• Baur JA Sinclair DA Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 2006 5 6 493 506 16732220
   PubMed Web of Science ®Google Scholar
• Howitz KT Bitterman KJ Cohen HY Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 2003 425 6954 191 196 12939617
   PubMed Web of Science ®Google Scholar
• Um JH Park SJ Kang H AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol Diabetes 2010 59 3 554 563 19934007
   PubMed Web of Science ®Google Scholar
• Hou X Xu S Maitland-Toolan KA SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase J Biol Chem 2008 283 29 20015 20026 18482975
   PubMed Web of Science ®Google Scholar
• Zang M Xu S Maitland-Toolan KA Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice Diabetes 2006 55 8 2180 2191 16873680
   PubMed Web of Science ®Google Scholar
• Baur JA Pearson KJ Price NL Resveratrol improves health and survival of mice on a high-calorie diet Nature 2006 444 7117 337 342 17086191
   PubMed Web of Science ®Google Scholar
• Park CE Kim MJ Lee JH Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase Exp Mol Med 2007 39 2 222 229 17464184
   PubMed Web of Science ®Google Scholar
• Dasgupta B Milbrandt J Resveratrol stimulates AMP kinase activity in neurons Proc Natl Acad Sci U S A 2007 104 17 7217 7222 17438283
   PubMed Web of Science ®Google Scholar
• Gledhill JR Montgomery MG Leslie AG Walker JE Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols Proc Natl Acad Sci U S A 2007 104 34 13632 13637 17698806
   PubMed Web of Science ®Google Scholar
• Cohen HY Miller C Bitterman KJ Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase Science 2004 305 5682 390 392 15205477
   PubMed Web of Science ®Google Scholar
• Ruderman NB Xu XJ Nelson L AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 2010 298 4 E751 E760 20103737
   PubMed Web of Science ®Google Scholar
• Mazibuko SE Muller CJ Joubert E Amelioration of palmitate-induced insulin resistance in C2C12 muscle cells by rooibos (Aspalathus linearis) Phytomedicine 2013 20 10 813 819 23639187
   PubMed Web of Science ®Google Scholar
• Beltrán-Debón R Rull A Rodríguez-Sanabria F Continuous administration of polyphenols from aqueous rooibos (Aspalathus linearis) extract ameliorates dietary-induced metabolic disturbances in hyperlipidemic mice Phytomedicine 2011 18 5 414 424 21211952
   PubMed Web of Science ®Google Scholar
• Son MJ Minakawa M Miura Y Yagasaki K Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice Eur J Nutr 2013 52 6 1607 1619 23238530
   PubMed Web of Science ®Google Scholar
• Lee YS Kim WS Kim KH Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states Diabetes 2006 55 8 2256 2264 16873688
   PubMed Web of Science ®Google Scholar
• Kong W Wei J Abidi P Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins Nat Med 2004 10 12 1344 1351 15531889
   PubMed Web of Science ®Google Scholar
• Yin J Xing H Ye J Efficacy of berberine in patients with type 2 diabetes mellitus Metabolism 2008 57 5 712 717 18442638
   PubMed Web of Science ®Google Scholar
• Cheng Z Pang T Gu M Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK Biochim Biophys Acta 2006 1760 11 1682 1689 17049164
   PubMed Web of Science ®Google Scholar
• Brusq JM Ancellin N Grondin P Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine J Lipid Res 2006 47 6 1281 1288 16508037
   PubMed Web of Science ®Google Scholar
• Kim SH Shin EJ Kim ED Bayaraa T Frost SC Hyun CK Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes Biol Pharm Bull 2007 30 11 2120 2125 17978486
   PubMed Web of Science ®Google Scholar
• Al-masri IM Mohammad MK Tahaa MO Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine J Enzyme Inhib Med Chem 2009 24 5 1061 1066 19640223
   PubMed Web of Science ®Google Scholar
• Sarna LK Wu N Hwang SY Siow YL Karmin O Berberine inhibits NADPH oxidase mediated superoxide anion production in macrophages Can J Physiol Pharmacol 2010 88 3 369 378 20393601
   PubMed Web of Science ®Google Scholar
• Turner N Li JY Gosby A Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action Diabetes 2008 57 5 1414 1418 18285556
   PubMed Web of Science ®Google Scholar
• Yin J Gao Z Liu D Liu Z Ye J Berberine improves glucose metabolism through induction of glycolysis Am J Physiol Endocrinol Metab 2008 294 1 E148 E156 17971514
   PubMed Web of Science ®Google Scholar
• Choi BH Kim YH Ahn IS Ha JH Byun JM Do MS The inhibition of inflammatory molecule expression on 3T3-L1 adipocytes by berberine is not mediated by leptin signaling Nutr Res Pract 2009 3 2 84 88 20016706
   PubMed Web of Science ®Google Scholar
• Lee WJ Song KH Koh EH Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle Biochem Biophys Res Commun 2005 332 3 885 891 15913551
   PubMed Web of Science ®Google Scholar
• Saha AK Xu XJ Lawson E Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle Diabetes 2010 59 10 2426 2434 20682696
   PubMed Web of Science ®Google Scholar
• Lee Y Naseem RH Park BH Alpha-lipoic acid prevents lipotoxic cardiomyopathy in acyl CoA-synthase transgenic mice Biochem Biophys Res Commun 2006 344 1 446 452 16603124
   PubMed Web of Science ®Google Scholar
• Lee WJ Lee IK Kim HS Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase Arterioscler Thromb Vasc Biol 2005 25 12 2488 2494 16224049
   PubMed Web of Science ®Google Scholar
• Kim MS Park JY Namkoong C Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase Nat Med 2004 10 7 727 733 15195087
   PubMed Web of Science ®Google Scholar
• Park KG Min AK Koh EH Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways Hepatology 2008 48 5 1477 1486 18972440
   PubMed Web of Science ®Google Scholar
• Targonsky ED Dai F Koshkin V alpha-lipoic acid regulates AMP-activated protein kinase and inhibits insulin secretion from beta cells Diabetologia 2006 49 7 1587 1598 16752177
   PubMed Web of Science ®Google Scholar
• Shen QW Zhu MJ Tong J Ren J Du M Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes Am J Physiol Cell Physiol 2007 293 4 C1395 C1403 17687000
   PubMed Web of Science ®Google Scholar
• Ziegler D Gries FA Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy Diabetes 1997 46 Suppl 2 S62 S66 9285502
   PubMed Web of Science ®Google Scholar
• van Dam PS Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives Diabetes Metab Res Rev 2002 18 3 176 184 12112935
   PubMed Web of Science ®Google Scholar
• Tartaglia LA Dembski M Weng X Identification and expression cloning of a leptin receptor, OB-R Cell 1995 83 7 1263 1271 8548812
   PubMed Web of Science ®Google Scholar
• Minokoshi Y Kim YB Peroni OD Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase Nature 2002 415 6869 339 343 11797013
   PubMed Web of Science ®Google Scholar
• Suzuki A Okamoto S Lee S Saito K Shiuchi T Minokoshi Y Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase Mol Cell Biol 2007 27 12 4317 4327 17420279
   PubMed Web of Science ®Google Scholar
• Tanaka T Masuzaki H Yasue S Central melanocortin signaling restores skeletal muscle AMP-activated protein kinase phosphorylation in mice fed a high-fat diet Cell Metab 2007 5 5 395 402 17488641
   PubMed Web of Science ®Google Scholar
• Andersson U Filipsson K Abbott CR AMP-activated protein kinase plays a role in the control of food intake J Biol Chem 2004 279 13 12005 12008 14742438
   PubMed Web of Science ®Google Scholar
• Yang Y Atasoy D Su HH Sternson SM Hunger states switch a flip-flop memory circuit via a synaptic AMPK-dependent positive feedback loop Cell 2011 146 6 992 1003 21925320
   PubMed Web of Science ®Google Scholar
• Richards AA Stephens T Charlton HK Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications Mol Endocrinol 2006 20 7 1673 1687 16497731
   PubMedGoogle Scholar
• Lim S Quon MJ Koh KK Modulation of adiponectin as a potential therapeutic strategy Atherosclerosis 2014 233 2 721 728 24603219
   PubMed Web of Science ®Google Scholar
• Hu E Liang P Spiegelman BM AdipoQ is a novel adipose-specific gene dysregulated in obesity J Biol Chem 1996 271 18 10697 10703 8631877
   PubMed Web of Science ®Google Scholar
• Yamauchi T Nio Y Maki T Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions Nat Med 2007 13 3 332 339 17268472
   PubMed Web of Science ®Google Scholar
• Mao X Kikani CK Riojas RA APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function Nat Cell Biol 2006 8 5 516 523 16622416
   PubMed Web of Science ®Google Scholar
• Hada Y Yamauchi T Waki H Selective purification and characterization of adiponectin multimer species from human plasma Biochem Biophys Res Commun 2007 356 2 487 493 17368570
   PubMed Web of Science ®Google Scholar
• Combs TP Berg AH Obici S Scherer PE Rossetti L Endogenous glucose production is inhibited by the adipose-derived protein Acrp30 J Clin Invest 2001 108 12 1875 1881 11748271
   PubMed Web of Science ®Google Scholar
• Fruebis J Tsao TS Javorschi S Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc Natl Acad Sci U S A 2001 98 4 2005 2010 11172066
   PubMed Web of Science ®Google Scholar
• Masaki T Chiba S Yasuda T Peripheral, but not central, administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in agouti yellow (Ay/a) obese mice Diabetes 2003 52 9 2266 2273 12941765
   PubMed Web of Science ®Google Scholar
• Ouchi N Kihara S Arita Y Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 2001 103 8 1057 1063 11222466
   PubMed Web of Science ®Google Scholar
• Yamauchi T Kamon J Waki H Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis J Biol Chem 2003 278 4 2461 2468 12431986
   PubMed Web of Science ®Google Scholar
• Kubota N Yano W Kubota T Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake Cell Metab 2007 6 1 55 68 17618856
   PubMed Web of Science ®Google Scholar
• Ruderman NB Keller C Richard AM Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome Diabetes 2006 55 Suppl 2 S48 S54 17130644
   PubMed Web of Science ®Google Scholar
• Pedersen BK Febbraio MA Muscle as an endocrine organ: focus on muscle-derived interleukin-6 Physiol Rev 2008 88 4 1379 1406 18923185
   PubMed Web of Science ®Google Scholar
• Kelly M Gauthier MS Saha AK Ruderman NB Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization Diabetes 2009 58 9 1953 1960 19502419
   PubMed Web of Science ®Google Scholar
• Kelly M Keller C Avilucea PR AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise Biochem Biophys Res Commun 2004 320 2 449 454 15219849
   PubMed Web of Science ®Google Scholar
• Carey AL Steinberg GR Macaulay SL Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase Diabetes 2006 55 10 2688 2697 17003332
   PubMed Web of Science ®Google Scholar
• Geiger PC Hancock C Wright DC Han DH Holloszy JO IL-6 increases muscle insulin sensitivity only at superphysiological levels Am J Physiol Endocrinol Metab 2007 292 6 E1842 E1846 17327367
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011 Atlanta, GA US Department of Health and Human Services, Centers for Disease Control and Prevention 2011
   Google Scholar
• Drummond MJ Dreyer HC Fry CS Glynn EL Rasmussen BB Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling J Appl Physiol 2009 106 4 1374 1384 19150856
   PubMed Web of Science ®Google Scholar
• McKiernan SH Colman RJ Lopez M Caloric restriction delays aging-induced cellular phenotypes in rhesus monkey skeletal muscle Exp Gerontol 2011 46 1 23 29 20883771
   PubMed Web of Science ®Google Scholar
• Mercken EM Crosby SD Lamming DW Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile Aging Cell 2013 12 4 645 651 23601134
   PubMed Web of Science ®Google Scholar